These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 24439760)
1. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients. Matthews JL; Dubovy SR; Goldberg RA; Flynn HW Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760 [TBL] [Abstract][Full Text] [Related]
2. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Goldberg RA; Flynn HW; Isom RF; Miller D; Gonzalez S Am J Ophthalmol; 2012 Feb; 153(2):204-208.e1. PubMed ID: 22264943 [TBL] [Abstract][Full Text] [Related]
3. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Goldberg RA; Flynn HW; Miller D; Gonzalez S; Isom RF Ophthalmology; 2013 Jul; 120(7):1448-53. PubMed ID: 23453511 [TBL] [Abstract][Full Text] [Related]
4. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. Sheyman AT; Cohen BZ; Friedman AH; Ackert JM JAMA Ophthalmol; 2013 Jul; 131(7):864-9. PubMed ID: 23640384 [TBL] [Abstract][Full Text] [Related]
5. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S Retina; 2008; 28(10):1395-9. PubMed ID: 18827737 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA; Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087 [TBL] [Abstract][Full Text] [Related]
8. The article by Fintak et al on the incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. El-Ashry MF; Dhillon B Retina; 2009 May; 29(5):720-1; author reply 721-2. PubMed ID: 19430287 [No Abstract] [Full Text] [Related]
9. Incidence of Endophthalmitis after Intravitreal Bevacizumab using Aliquots Prepared On-site in 2 Operating Rooms in Kuwait. Wani VB; Al-Kandari J; Sabti K; Aljassar F; Qali H; Kumar N; Uboweja A; Al-Sabah K; Diab FA; Al-Rashidi S Middle East Afr J Ophthalmol; 2016; 23(1):64-70. PubMed ID: 26957841 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815 [TBL] [Abstract][Full Text] [Related]
11. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Small KW; Chan CK; Silva-Garcia R; Walsh TJ Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858 [TBL] [Abstract][Full Text] [Related]
12. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743 [TBL] [Abstract][Full Text] [Related]
13. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome. Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C; Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127 [TBL] [Abstract][Full Text] [Related]
14. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection. Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA Retina; 2013; 33(7):1407-16. PubMed ID: 23492945 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor. Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A Retina; 2010; 30(7):1051-7. PubMed ID: 20616683 [TBL] [Abstract][Full Text] [Related]
16. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358 [TBL] [Abstract][Full Text] [Related]
17. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration. Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A Retina; 2007; 27(4):432-8. PubMed ID: 17420694 [TBL] [Abstract][Full Text] [Related]
19. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China. Wang F; Yu S; Liu K; Chen FE; Song Z; Zhang X; Xu X; Sun X Ophthalmology; 2013 Feb; 120(2):355-61. PubMed ID: 23084126 [TBL] [Abstract][Full Text] [Related]
20. Aggressive Surgical Therapy With Early Vitrectomy, Panretinal Photocoagulation, and Silicone Oil Tamponade for Streptococcus mitis Endophthalmitis. Thomas BJ; Yonekawa Y; Ruby AJ; Capone A Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):893-5. PubMed ID: 26431308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]